已经报道了一种合成1,5-和1,4,5-取代的1,2,3-三唑的新方法。使用烯胺和N-甲苯磺酰肼作为原料的碘-TBHP氧化系统促进了这种方法,避免了传统方法对叠氮化物和过渡金属的依赖。通过这种方法,各种1,5-和1,4,5-取代的1,2,3-三唑以中等到高产量提供。机理研究表明,氨基交换将参与反应过程。此外,产品1-(2-甲氧基苯基)-4-甲基-1 H -1,2,3-三唑-5-羧酸甲酯是抗甲型流感药物的有用前体,并进行了进一步的应用研究。
已经报道了一种合成1,5-和1,4,5-取代的1,2,3-三唑的新方法。使用烯胺和N-甲苯磺酰肼作为原料的碘-TBHP氧化系统促进了这种方法,避免了传统方法对叠氮化物和过渡金属的依赖。通过这种方法,各种1,5-和1,4,5-取代的1,2,3-三唑以中等到高产量提供。机理研究表明,氨基交换将参与反应过程。此外,产品1-(2-甲氧基苯基)-4-甲基-1 H -1,2,3-三唑-5-羧酸甲酯是抗甲型流感药物的有用前体,并进行了进一步的应用研究。
Exploring the Oxidative Cyclization of Substituted
<i>N</i>
‐Aryl Enamines: Pd‐Catalyzed Formation of Indoles from Anilines
作者:Julia J. Neumann、Souvik Rakshit、Thomas Dröge、Sebastian Würtz、Frank Glorius
DOI:10.1002/chem.201100631
日期:2011.6.20
The direct Pd‐catalyzed oxidative coupling of twoCH‐bonds within N‐aryl‐enamines 1 allows the efficient formation of differently substituted indoles 2. In this cross‐dehydrogenative coupling, many different functional groups are tolerated and the starting material N‐aryl‐enamines 1 can be easily prepared in one step from commercially available anilines. In addition, the whole sequence can also be
Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
申请人:Gielen-Haertwig Heike
公开号:US20070167406A1
公开(公告)日:2007-07-19
The invention relates to novel dihydropyridine derivatives, of Formula (I) processes for their preparation, and their use in medicaments, especially for the treatment of chronic obstructive pulmonary diseases, acute coronary syndrome, acute myocardial infarction and heart failure development.